- Sputnik International, 1920
World
Get the latest news from around the world, live coverage, off-beat stories, features and analysis.

Bank of England Warns of Case Spikes and Economic Hurdles if Vaccine-Resistant Virus Variants Emerge

CC BY-SA 2.0 / Images George Rex / Bank of England
Bank of England - Sputnik International, 1920, 04.02.2021
Subscribe
The statement comes as Public Health England on Monday said that a new mutation of the coronavirus strain detected in December could potentially be impervious to vaccines.

The potential emergence of vaccine-resistant coronavirus mutations could spark the renewed growth of infection rates which then could entail further restriction on economic activities in the future, the Bank of England said on Thursday.

South Africa and the UK have both detected coronavirus variants that appear to be transmitted more rapidly than other strains. The UK strain is believed to be up to 70 percent more transmissible. It was first discovered in southeast England and subsequently spread rapidly throughout the United Kingdom and continental Europe.

© REUTERS / HANNAH MCKAYA woman is given a protective face mask as she waits to receive the COVID-19 vaccine at Crystal Palace Football Club Vaccination Centre, amid the outbreak of the coronavirus disease (COVID-19) in London, Britain February 4, 2021.
Bank of England Warns of Case Spikes and Economic Hurdles if Vaccine-Resistant Virus Variants Emerge - Sputnik International, 1920, 04.02.2021
A woman is given a protective face mask as she waits to receive the COVID-19 vaccine at Crystal Palace Football Club Vaccination Centre, amid the outbreak of the coronavirus disease (COVID-19) in London, Britain February 4, 2021.

On Monday, Public Health England published a new analysis of the new strain which showed that its so-called E484K mutation could make the virus resistant to vaccines, while enabling it to infect those who've already defeated COVID-19.

The United Kingdom is currently reporting 3,852,627 coronavirus cases and 108,013 fatalities, according to the latest data by the WHO. Over the past month, the number of cases in the United Kingdom has been gradually declining, compared to December and early January figures which saw continuous growth in infections.

Just over 10 million people in the United Kingdom have already received their first dose of either the Pfizer/BioNTech or AstraZeneca/Oxford COVID-19 vaccine as part of the government’s plan to immunise 15 million people from the top four groups — the over 70s, health workers, care home staff, and clinically vulnerable patients — by mid-February.

Newsfeed
0
To participate in the discussion
log in or register
loader
Chats
Заголовок открываемого материала